June 2015, Volume 1, Issue 6

June 2015

Volume 1, Issue 6

This month, we take an in-depth look at the work that hematology advocates are doing, the latest research from Blood, and the latest hematology/oncology news.

Table of Contents

June 2015

Managing the Oral Health Complications of Chemotherapy

Monday, June 1st, 2015
What are the oral complications of cancer therapy that hematologists/oncologists should be aware of? The treatments for hematologic malignancies – chemotherapy, combinations of chemotherapy, or...

A Primer on Conference Call Etiquette

Monday, June 1st, 2015
We’ve all been there. At precisely 2:59 p.m. you pick up the phone handset and dial into the conference call scheduled to start in the...

June 2015

New Podcasts from The Hematologist, ASH’s Comments on USPSTF’s Anemia Recommendations, and the MDS...

Monday, June 1st, 2015
A New Way to Catch Up with ASH News and Reports: The Hematologist Podcasts To better serve the Society’s membership by bringing new digital offerings, The Hematologist has launched...

Remembering Aaron J. Marcus and Gerald Robbins, New Howard Hughes Investigators Named for 2015,...

Monday, June 1st, 2015
Aaron J. Marcus, MD (1925-2015) Aaron J. Marcus, MD, a mentor and pioneering scientist in hemostasis, coagulation, thrombosis, and vascular biology for 52 years, passed...

June 2015

Now Entering the Ring: Marc J. Kahn, MD, MBA

Monday, June 1st, 2015
When did your interest in boxing start? I have followed the sport since I was a kid. I would watch the Gillette Friday Night Fights on...

A Day on the Hill: The ASH Committee on Practice Goes to Washington

Monday, June 1st, 2015
On May 19, 2015, following its spring meeting in Washington, DC, members of the ASH Committee on Practice visited more than 40 congressional offices...

Grassroots Lobbying Efforts Lead to a Win for SCD Patients in Tennessee: An Interview...

Monday, June 1st, 2015
Sickle cell disease (SCD) is the most common, inherited red blood cell disorder in the United States – affecting 70,000 to 100,000 Americans. Although...

June 2015

Get Screened to Know Your Sickle Cell Status

Monday, June 1st, 2015
To find out whether you or your loved one has sickle cell disease (SCD) or sickle cell trait (SCT), blood tests must be done to screen...

When should I order gene studies to establish clonality and rule out B-cell lymphoproliferative...

Monday, June 1st, 2015
This month, Carol S. Portlock, MD, advises on gene studies to establish clonality in B-cell lymphoproliferative disorders.I perform T-cell receptor gene studies to establish clonality...

June 2015

WIB_icon

HIT or Miss: Is a Gel Immunoassay Better Than the 4Ts Score?

Monday, June 1st, 2015
A fraction of patients taking the anticoagulant heparin will develop heparin-induced thrombocytopenia (HIT) – an adverse drug reaction caused by IgG platelet-activating antibodies that...

BCR-ABL1 Inhibitor Axitinib Overcomes Drug Resistance in CML

Monday, June 1st, 2015
While selective BCR-ABL tyrosine kinase inhibitors (TKIs) have markedly improved outcomes for patients with chronic myeloid leukemia (CML), they are not as effective in...

FDA to Lift Ban on Blood Donations from Gay Men, the House Approves the...

Monday, June 1st, 2015
FDA Plans to Lift Ban on Blood Donations from Gay Men In 1983, shortly after the onset of the AIDS epidemic, the U.S. Food and...
WIB_icon

Therapeutic Anticoagulation Safe for Patients with Brain Metastases

Monday, June 1st, 2015
While approximately one in five patients with brain metastases will develop a venous thromboembolism (VTE), there is limited evidence about the safety of anticoagulation...
WIB_icon

Outcomes with Azacitidine Similar to Other Treatments for Older Patients with AML

Monday, June 1st, 2015
Older patients with acute myeloid leukemia (AML) may benefit similarly from treatment with the hypomethylating agent azacitidine as they do to other chemotherapy approaches,...
WIB_icon

Race-Specific Dosing Guidelines Urged for Warfarin

Monday, June 1st, 2015
Since the National Institutes of Health issued a call for broader racial representation in clinical research, clinicians and researchers have met that challenge with...

Germline Mutation in Leukemia Highlights Disease Complexity

Monday, June 1st, 2015
A recent report published in Nature Genetics has underscored the key role that the ETV6 gene plays in platelet formation and leukemia predisposition.1 Researchers...

Serum Free Light Chain Measurement Has Prognostic Value in All Stages of Myeloma

Monday, June 1st, 2015
A normalized serum free light chain (sFLC) ratio in multiple myeloma treatment following a complete response has been tied to better survival. For those...

June 2015

SHARE